These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8067283)
41. Carcinogen biomarkers for lung or oral cancer chemoprevention trials. Hecht SS IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664 [TBL] [Abstract][Full Text] [Related]
42. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis. Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216 [TBL] [Abstract][Full Text] [Related]
43. Application of biomarkers to risk assessment. Gaylor DW; Kadlubar FF; Beland FA Environ Health Perspect; 1992 Nov; 98():139-41. PubMed ID: 1486842 [TBL] [Abstract][Full Text] [Related]
44. Human exposure monitoring, dosimetry, and cancer risk assessment: the use of antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA. Poirier MC Drug Metab Rev; 1994; 26(1-2):87-109. PubMed ID: 8082583 [No Abstract] [Full Text] [Related]
45. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: implications for human biotransformation enzyme polymorphisms. Eaton DL; Bammler TK; Kelly EJ Adv Exp Med Biol; 2001; 500():559-76. PubMed ID: 11764998 [TBL] [Abstract][Full Text] [Related]
46. Comparative formation and removal of aflatoxin B1-DNA adducts in cultured mammalian tracheal epithelium. Ball RW; Wilson DW; Coulombe RA Cancer Res; 1990 Aug; 50(16):4918-22. PubMed ID: 2116221 [TBL] [Abstract][Full Text] [Related]
47. Modulation of mycotoxin and nitrosamine carcinogenesis by indole-3-carbinol: quantitative analysis of inhibition versus promotion. Bailey GS; Dashwood RH; Fong AT; Williams DE; Scanlan RA; Hendricks JD IARC Sci Publ; 1991; (105):275-80. PubMed ID: 1906835 [TBL] [Abstract][Full Text] [Related]
48. Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study. Peluso M; Airoldi L; Munnia A; Colombi A; Veglia F; Autrup H; Dunning A; Garte S; Gormally E; Malaveille C; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita BH; Peeters PH; Kumle M; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Tormo MJ; Quiros JR; Berglund G; Jarvholm B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Bingham S; Vineis P Br J Nutr; 2008 Sep; 100(3):489-95. PubMed ID: 18275627 [TBL] [Abstract][Full Text] [Related]
49. Nearest neighbor effects on carcinogen binding to guanine runs in DNA. Said B; Shank RC Nucleic Acids Res; 1991 Mar; 19(6):1311-6. PubMed ID: 1903201 [TBL] [Abstract][Full Text] [Related]
50. DNA binding and adduct formation of aflatoxin B1 in cultured human and animal tracheobronchial and bladder tissues. Stoner GD; Daniel FB; Schenck KM; Schut HA; Sandwisch DW; Gohara AF Carcinogenesis; 1982; 3(11):1345-8. PubMed ID: 6817939 [No Abstract] [Full Text] [Related]
51. Immunologic methods for the detection of carcinogen adducts in humans. Santella RM; Yang XY; Hsieh LL; Young TL Prog Clin Biol Res; 1990; 340C():247-57. PubMed ID: 2199982 [TBL] [Abstract][Full Text] [Related]
52. Comparative effect of dietary butylated hydroxyanisole and beta-naphthoflavone on aflatoxin B1 metabolism, DNA adduct formation, and carcinogenesis in rainbow trout. Goeger DE; Shelton DW; Hendricks JD; Pereira C; Bailey GS Carcinogenesis; 1988 Oct; 9(10):1793-800. PubMed ID: 3139317 [TBL] [Abstract][Full Text] [Related]
53. Repair of DNA adducts of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one in mouse tissues and its relation to tumor induction. Abbott PJ; Crew F Cancer Res; 1981 Oct; 41(10):4115-20. PubMed ID: 7285015 [TBL] [Abstract][Full Text] [Related]
54. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility. Badawi AF; Stern SJ; Lang NP; Kadlubar FF Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986 [TBL] [Abstract][Full Text] [Related]
55. Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention. Hecht SS Ann N Y Acad Sci; 1997 Dec; 833():91-111. PubMed ID: 9616743 [TBL] [Abstract][Full Text] [Related]
56. Aflatoxin B1-2,3-oxide: evidence for its formation in rat liver in vivo and by human liver microsomes in vitro. Swenson DH; Miller EC; Miller JA Biochem Biophys Res Commun; 1974 Oct; 60(3):1036-43. PubMed ID: 4429559 [No Abstract] [Full Text] [Related]
57. The use of antibodies to detect carcinogen - DNA adducts in vivo and in vitro. Poirier MC Prog Clin Biol Res; 1983; 132B():289-98. PubMed ID: 6685294 [No Abstract] [Full Text] [Related]
58. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure. Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179 [TBL] [Abstract][Full Text] [Related]
59. Characterization and properties of the DNA adducts formed from N-methyl-4-aminoazobenzene in rats during a carcinogenic treatment regimen. Tullis DL; Dooley KL; Miller DW; Baetcke KP; Kadlubar FF Carcinogenesis; 1987 Apr; 8(4):577-83. PubMed ID: 3829320 [TBL] [Abstract][Full Text] [Related]
60. Presence of mucosa-specific DNA adduct in human colon: possible implication for colorectal cancer. Umemoto A; Kajikawa A; Tanaka M; Hamada K; Seraj MJ; Kubota A; Nakayama M; Kinouchi T; Ohnishi Y; Yamashita K Carcinogenesis; 1994 May; 15(5):901-5. PubMed ID: 8200093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]